Showing results (331-340 of 341) with videos related to
Sort By:
Pageof 35
The British Journal of Nutrition|January 2, 2026
Relative validity of an online short FFQ assessing the Dutch adapted version of the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet in older adults at risk of cognitive declineSonja Beers, Sofie van Houdt, Lisette C P G M de Groot, et al.Genomics|December 10, 1999
Pseudoxanthoma elasticum maps to an 820-kb region of the p13.1 region of chromosome 16O Le Saux, Z Urban, H H Göring, et al.Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|November 17, 2009
Long-term functional outcome in 167 patients with syndromic craniosynostosis; defining a syndrome-specific risk profileT de Jong, N Bannink, H H Bredero-Boelhouwer, et al.BMC Medicine|January 8, 2024
Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 statusYuwei Wang, Gwen M H E Dackus, Efraim H Rosenberg, et al.BMJ (Clinical Research Ed.)|July 12, 2022
Clinical prediction models for mortality in patients with covid-19: external validation and individual participant data meta-analysisValentijn M T de Jong, Rebecca Z Rousset, Neftalí Eduardo Antonio-Villa, et al.British Journal of Clinical Pharmacology|August 11, 2023
Adverse drug events caused by three high-risk drug-drug interactions in patients admitted to intensive care units: A multicentre retrospective observational studyJoanna E Klopotowska, Jan-Hendrik Leopold, Tinka Bakker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2022
Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic TherapyVincent M T de Jong, Yuwei Wang, Natalie D Ter Hoeve, et al.BMJ (Clinical Research Ed.)|April 9, 2020
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisalLaure Wynants, Ben Van Calster, Gary S Collins, et al.The Lancet. Oncology|June 29, 2026
Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trialRianne L Seefat, Sonja B Vliek, Vincent M T de Jong, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 23, 2026
Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survivalY Wang, D Drubay, S F Jonas, et al.Pageof 35